AnPac Bio-Medical Science Co., Ltd. (ANPC) |
|
8.68 -0.09 (-1.03%)
|
02-02 15:59 |
|
Open: |
9 |
Pre. Close: |
8.77 |
|
High:
|
9.1 |
Low:
|
8.51 |
|
Volume:
|
13,154 |
Market Cap:
|
18(M) |
|
|
|
Technical analysis |
as of: 2023-02-02 4:28:46 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 14 One year: 16.35 |
| Support: |
Support1: 6.92  Support2: 3.79 |
| Resistance: |
Resistance1: 11.98 Resistance2: 14 |
| Pivot: |
8.35 |
| Moving Average: |
MA(5): 8.53  MA(20): 7.66
MA(100): 4.52 MA(250): 6.32 |
| MACD: |
MACD(12,26): 1 Signal(9): 1 |
| Stochastic oscillator: |
%K(14,3): 47.7 %D(3): 47.4 |
| RSI: |
RSI(14): 62.4 |
| 52-week: |
High: 18.65 Low: 0.25 |
| Average Vol(K): |
3-Month: 38 (K) 10-Days: 47 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ANPC ] has closed below upper band by 41.0%. Bollinger Bands are 75.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 17 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.11 - 9.16 |
9.16 - 9.21 |
|
Low:
|
8.4 - 8.45 |
8.45 - 8.5 |
|
Close:
|
8.6 - 8.69 |
8.69 - 8.77 |
|
Company Description |
|
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China. |
Headline News |
Thu, 02 Feb 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace
Wed, 01 Feb 2023
Why TransCode Therapeutics Shares Are Trading Higher By 42 ... - Investing.com UK
Wed, 01 Feb 2023
Premarket Mover: AnPac Bio-Medical Science Co Ltd - ADR (ANPC) Down 14.37% - InvestorsObserver
Tue, 31 Jan 2023
Computer model predicts who will recover from COVID-19 - Medical Xpress
Mon, 30 Jan 2023
Togo Floods Operational Update (MDRTG009) - Togo - ReliefWeb
Thu, 26 Jan 2023
TOGO: In Dapaong, a school manual for natural disaster prevention - AFRIK 21
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
0 (M) |
| Shares Float |
2 (M) |
|
% Held by Insiders
|
1.78e+006 (%) |
|
% Held by Institutions
|
7.2 (%) |
|
Shares Short
|
92 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-7.371e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-491.5 |
|
Return on Assets (ttm)
|
-69.9 |
|
Return on Equity (ttm)
|
-2 |
|
Qtrly Rev. Growth
|
1.591e+007 |
|
Gross Profit (p.s.)
|
33.96 |
|
Sales Per Share
|
752.46 |
|
EBITDA (p.s.)
|
9.35115e+006 |
|
Qtrly Earnings Growth
|
-1.1 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0.01 |
|
Price to Cash Flow
|
-7.07 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
90270 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
